March 28 (Reuters) - Kodiak Sciences Inc KOD.O :
* KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND
FOURTH
QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
* ENDED Q4 OF 2023 WITH $285.5 MILLION OF CASH AND CASH
EQUIVALENTS
* PHASE 1B STUDY OF KSI-101 PLANNED FOR 2Q2024 WITH GOAL OF
INITIATING DUAL PIVOTAL STUDIES IN 2024
* QTRLY LOSS PER SHARE $1.13
* BELIEVE EXISTING CASH WILL BE SUFFICIENT TO SUPPORT
CURRENT AND
PLANNED OPERATIONS INTO 2026
* Q4 EARNINGS PER SHARE VIEW $-0.77 -- LSEG IBES DATA
Source text for Eikon: ID:nPn60kgSNa
Further company coverage: KOD.O
((Reuters.Briefs@thomsonreuters.com;))